Vir Biotechnology, Inc. (Nasdaq: VIR) today provided key program updates, including new positive data from the ongoing SOLSTICE Phase 2 trial in chronic hepatitis delta (CHD). Participants receiving ...
Bioprinting is rapidly moving from research labs into commercial reality, and it is reshaping how the pharmaceutical and ...
Learn how spectroscopy facilitates non-invasive, real-time bio-monitoring, enhancing decision-making in healthcare, ...
Insmed's CEO said months ago that the commercial opportunity for the biotech's newly approved lung disease drug was "huge." ...
2don MSN
Biotechnology is the future. India poised to harness human & biological wealth: Dr. Jitendra Singh
India’s 21st century growth story is turning biological. From vaccines to genome sequencing and green fuels, biotechnology is ...
Like other developing countries, Indonesia is facing a familiar dilemma: how to feed a growing population while protecting ...
A successful Phase 3 trial and a public offeringof stock boosted prospects for this company to receive approval for an ...
Sulfolobus islandicus, an archaeal model organism, offers unique advantages for metabolic engineering and synthetic biology ...
GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, is proud to announce its 5th ...
Atlantic County Institute of Technology (ACIT) is in the final group of county vocational-technical schools to complete its ...
Using a technique called ancestral sequence reconstruction (ASR), researchers at Wageningen University & Research in the ...
A team of researchers led by bioengineer Shaochen Chen will use 3D printing techniques to shape stem cells produced by local firm Allele Biotechnology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback